Welcome
Dear Friends and Colleagues,
It is our pleasure to welcome you to the 78th Mosbacher Kolloquium of the German Society for Biochemistry and Molecular Biology (GBM), held once again in the charming town of Mosbach. Entitled “Precision Cancer Medicine – From Molecular Mechanisms to Therapeutic Innovation”, this year's meeting will explore how molecular insights into cancer can be translated into more precise and effective therapies.
Precision oncology has transformed cancer research and clinical practice through genomic profiling and biomarker-guided therapies. However, the next generation of precision cancer medicine requires integrating cancer genetics, functional genomics, AI-driven prediction, and innovative therapeutic modalities to identify actionable vulnerabilities and improve patient care.
The programme will bring together internationally leading scientists to discuss four interconnected themes: From Target Discovery to the Clinic, Therapeutic Decision-Making, Drugging the Undruggable, and New Drug Modalities. An introductory session on AI in Precision Cancer Medicine will highlight the growing role of computational approaches in cancer research and clinical decision-making.
As always, the Mosbacher Kolloquium will provide an outstanding forum for scientific exchange and for fostering interactions between established investigators and the next generation of researchers.
We look forward to welcoming you to Mosbach in 2027 for an inspiring meeting filled with exciting science, lively discussions, and new collaborations.
With best regards,
The Scientific Committee
Manuel Kaulich & Claudia Scholl
Organization & Contact
Goethe University Frankfurt
German Cancer Research Center (DKFZ) Heidelberg